Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/30587
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-01-23T07:02:35Z-
dc.date.available2023-01-23T07:02:35Z-
dc.date.issued2017-12-10-
dc.identifier.citationAlver, O. vd. (2017). ''A clinical scoring system for diagnosis of ocular demodicosis''. Medical Science Monitor, 23, 5862-5869.en_US
dc.identifier.issn1643-3750-
dc.identifier.urihttps://doi.org/10.12659/MSM.907824-
dc.identifier.urihttps://medscimonit.com/abstract/index/idArt/907824-
dc.identifier.urihttp://hdl.handle.net/11452/30587-
dc.description.abstractBackground: Demodex may cause chronic and refractory blepharitis with associated ocular surface problems, and its diagnosis and treatment can be quite challenging. In this study, our aim was to assess the efficacy of tea tree oil in Demodex treatment on caucasian patients in an industrialized region of Turkey, and to develop a systematic scoring system for extremely accurate diagnosis in the absence of advanced facilities. Material/Methods: Charts of 412 patients with blepharitis were reviewed. A group of 39 out of 412 cases were identified as chronic and treatment-refractory, and therefore were enrolled in this study. Eyelashes from each of the lower and upper eyelids of both eyes were evaluated at x40 and x100 magnification using light microscopy. Treatment was started with 4% tea tree oil eyelid gel and 10% eyelash shampoo. Symptoms and findings were scored according to the most common complaints. Results: The mean age of the patients was 54.1 +/- 15.4 years. Seventeen (43.5%) patients were male and 22 (56.5%) patients were female. In 30 out of the 39 patients (76.9%) D. folliculorum was detected. Symptoms disappeared in 25 patients. The mean score of patients who were Demodex-negative was 2.7 +/- 1.0, and the mean score of patients who were Demodex-positive was 3.8 +/- 1.6 (p=0.047). Ninety-four percent of those with a score of 4 and over were found to be Demodex-positive (p=0.025). Conclusions: Treatment with tea tree oil can be successful. If there is no facility to identify Demodex under light microscopy, we recommend starting treatment for patients who have scores of 4 and over using the scoring chart developed in this study.en_US
dc.language.isoenen_US
dc.publisherInt Scientific Informationen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectResearch & experimental medicineen_US
dc.subjectDry eye syndromesen_US
dc.subjectKeratitisen_US
dc.subjectMite infestationsen_US
dc.subjectOcular surfaceen_US
dc.subjectScoreen_US
dc.subjectTea tree oilen_US
dc.subjectDemodex blepharitisen_US
dc.subjectCase seriesen_US
dc.subjectInfestationen_US
dc.subjectFolliculorumen_US
dc.subjectDiscomforten_US
dc.subjectSymptomsen_US
dc.subjectPatienten_US
dc.subjectDiseaseen_US
dc.subjectGelen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAnti-infective agents, localen_US
dc.subject.meshBlepharitisen_US
dc.subject.meshEyeen_US
dc.subject.meshEyelashesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshTea tree oilen_US
dc.subject.meshTurkeyen_US
dc.titleA clinical scoring system for diagnosis of ocular demodicosisen_US
dc.typeArticleen_US
dc.identifier.wos000417955400002tr_TR
dc.identifier.scopus2-s2.0-85039736351tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Mikrobiyoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Göz Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-4803-8206tr_TR
dc.contributor.orcid0000-0003-0995-5260tr_TR
dc.contributor.orcid0000-0002-0932-6977tr_TR
dc.identifier.startpage5862tr_TR
dc.identifier.endpage5869tr_TR
dc.identifier.volume23tr_TR
dc.relation.journalMedical Science Monitoren_US
dc.contributor.buuauthorAlver, Oktay-
dc.contributor.buuauthorKıvanç, Sertaç Argün-
dc.contributor.buuauthorBudak, Berna Akova-
dc.contributor.buuauthorTüzemen, Nazmiye Ülkü-
dc.contributor.buuauthorEner, Beyza-
dc.contributor.buuauthorÖzmen, Ahmet Tuncer-
dc.contributor.researcheridAAA-5241-2021tr_TR
dc.contributor.researcheridAAG-8523-2021tr_TR
dc.contributor.researcheridA-4290-2018tr_TR
dc.contributor.researcheridAAH-6518-2021tr_TR
dc.contributor.researcheridABE-3033-2020tr_TR
dc.identifier.pubmed29224027tr_TR
dc.subject.wosMedicine, research & experimentalen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.contributor.scopusid24070021900tr_TR
dc.contributor.scopusid47861204900tr_TR
dc.contributor.scopusid55370489800tr_TR
dc.contributor.scopusid56100399900tr_TR
dc.contributor.scopusid15053025300tr_TR
dc.contributor.scopusid6701399730tr_TR
dc.subject.scopusDemodex; Demodicosis; Blepharitisen_US
dc.subject.emtreeShampooen_US
dc.subject.emtreeTea tree oilen_US
dc.subject.emtreeTopical antiinfective agenten_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBiomicroscopyen_US
dc.subject.emtreeBlepharitisen_US
dc.subject.emtreeComparative effectivenessen_US
dc.subject.emtreeDacryocystitisen_US
dc.subject.emtreeDemodexen_US
dc.subject.emtreeDemodicosisen_US
dc.subject.emtreeDry eyeen_US
dc.subject.emtreeEye burningen_US
dc.subject.emtreeEye painen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGlaucomaen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKeratitisen_US
dc.subject.emtreeLower eyeliden_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMicroscopyen_US
dc.subject.emtreeScoring systemen_US
dc.subject.emtreeUpper eyeliden_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeBlepharitisen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeEyeen_US
dc.subject.emtreeEyelashen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeTurkey (bird)en_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Alver_vd_2017.pdf223.21 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons